Bristol-Myers Squibb (NY: BMY )
42.16
+0.23
(+0.56%)
Streaming Delayed Price
Updated: 12:35 PM EDT, Jun 24, 2024
Add to My Watchlist
Headline News about Bristol-Myers Squibb![]() Via Benzinga
![]() ![]()
Bristol Myers' Deucravacitinib Scores FDA Approval For Plaque Psoriasis
September 12, 2022
Via Benzinga
![]() ![]() Via Benzinga
![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]()
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
August 23, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary
August 10, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|